Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Carsten Schaepers"'
Autor:
Jan Braess, Frank Ueckeroth, Diana S.Y. Abdulla, Carina Heydt, Anna-Kristina Eisert, Frank Beckers, Wolfram Meister, Hans-Joachim Kabitz, Johann Lorenzen, Monika Serke, Sabine Merkelbach-Bruse, Sebastian Michels, Jana Fassunke, Florian Kron, A. Meyer, Gabriele Wessling, Lucia Nogova, Bernhard Schaaf, Juliane Sueptitz, Matthias Scheffler, Carsten Schaepers, Sophia Koleczko, Reinhard Buettner, Clemens Schulte, Britta Kaminsky, Richard F. Riedel, Anna Kron, Stefan Krueger, Wolfgang Schulte, Joachim Lorenz, Michael Hamm, Kato Kambartel, Anne M. Schultheis, Christian Grohé, Jürgen Wolf, Lea Ruge, Jutta Kappes, Jens Panse, Niels Reinmuth, Rieke Fischer
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 16(4)
Robust data on the outcome of MET-aberrant NSCLC with nontargeted therapies are limited, especially in consideration of the heterogeneity of MET-amplified tumors (METamp).A total of 337 tumor specimens of patients with MET-altered Union for Internati
Autor:
Carsten Schaepers, Roman K. Thomas, Martin L. Sos, Jürgen Wolf, Imke Sauerland, Lars Hagmeyer, Reinhard Büttner, Karl-Otto Kambartel, Rebecca Hein, Lucia Nogova, Joachim Lorenz, Diana S.Y. Abdulla, Leonie Gogl, Martin Peifer, Nima Abedpour, Christian Grohé, Martin Hellmich, Johannes Brägelmann, Sophia Koleczko, Sabine Merkelbach-Bruse, Sebastian Michels, Merle Schüller, Ulrich Gerigk, Helen Pasternack, Matthias Scheffler, Rieke Fischer, Michaela Angelika Ihle, Monika Serke, Winfried Randerath, Jana Fassunke, Alessandra Holzem, Britta Kaminsky, Andreas H. Scheel, Anna Kron, Yon-Dschun Ko, Frank Ueckeroth, Wolfgang Schulte, Rieke Frank, Richard F. Riedel, Janna Siemanowski, Carina Heydt, Anna Eisert
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 14(4)
Introduction Although KRAS mutations in NSCLC have been considered mutually exclusive driver mutations for a long time, there is now growing evidence that KRAS-mutated NSCLC represents a genetically heterogeneous subgroup. We sought to determine gene
Autor:
Martin L. Sos, Juergen Wolf, Matthias Scheffler, Andreas H. Scheel, Sophia Koleczko, Carsten Schaepers, Frank Ueckeroth, Sabine Merkelbach-Bruse, Sebastian Michels, Leonie Gogl, Martin Hellmich, Rieke Fischer, Rieke Frank, Johannes Braegelmann, Anna Kostenko, Rebecca Hein, Michaela Angelika Ihle, Anna Eisert, Reinhard Buettner, Florian Kron
Publikováno v:
Journal of Clinical Oncology. 34:9018-9018
9018Background: KRAS mutations in non-small cell lung cancer (NSCLC) still remain therapeutically untargetable. Assuming that these mutations are not mutually exclusive with other driver aberration...